PP
MRVI icon

PDT Partners’s Maravai LifeSciences MRVI Stock Holding History

PDT Partners’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-135,819
Closed -$972K – 783
2024
Q2 		$972K Buy
+135,819
New +$1.17M 0.09% 338
2023
Q4 		– Sell
-134,451
Closed -$1.34M – 626
2023
Q3 		$1.34M Buy
134,451
+35,484
+36% +$390K 0.17% 200
2023
Q2 		$1.23M Sell
98,967
-8,143
-8% -$110K 0.17% 200
2023
Q1 		$1.5M Buy
+107,110
New +$1.54M 0.2% 180
2022
Q3 		– Sell
-22,029
Closed -$626K – 992
2022
Q2 		$626K Buy
22,029
+10,762
+96% +$341K 0.06% 543
2022
Q1 		$397K Sell
11,267
-2,035
-15% -$68.2K 0.03% 639
2021
Q4 		$557K Sell
13,302
-7,597
-36% -$308K 0.04% 498
2021
Q3 		$1.03M Buy
20,899
+4,100
+24% +$200K 0.07% 335
2021
Q2 		$701K Buy
+16,799
New +$651K 0.05% 445

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

PDT Partners's MRVI Position: Q3 2024 in Review

PDT Partners sold out of Maravai LifeSciences (MRVI) in Q3 2024, closing a stake of 135,819 shares — an estimated $972K sold.

PDT Partners first reported a position in MRVI in Q2 2021 and held it in 9 quarters. The position peaked at $1.5M in Q1 2023. 217 funds tracked by Wall St. Rank hold MRVI as of Q3 2024.

  • PDT Partners reported no remaining Maravai LifeSciences position as of Q3 2024 after selling out during the quarter.
  • PDT Partners sold 135,819 Maravai LifeSciences shares in Q3 2024, an estimated $972K.
  • PDT Partners first reported a position in Maravai LifeSciences in Q2 2021 and held it in 9 quarters.
  • PDT Partners's Maravai LifeSciences position peaked at $1.5M in Q1 2023.
  • 217 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2024.

Based on PDT Partners's 13F filing for Q3 2024, filed 14 Nov 2024.